DIVA Laboratories, Ltd. (TPEX:4153)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.00
-0.15 (-0.47%)
Apr 20, 2026, 1:24 PM CST
Market Cap1.88B -18.8%
Revenue (ttm)868.84M +0.8%
Net Income90.54M -3.3%
EPS1.54 -3.1%
Shares Out58.67M
PE Ratio20.78
Forward PEn/a
Dividend1.48 (4.61%)
Ex-Dividend DateJun 13, 2025
Volume1,000
Average Volume54,109
Open31.75
Previous Close32.00
Day's Range31.75 - 32.20
52-Week Range31.40 - 44.00
Beta0.30
RSI35.49
Earnings DateApr 28, 2026

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers emergency room/ operating ... [Read more]

Sector Healthcare
Founded 1995
Employees 154
Stock Exchange Taipei Exchange
Ticker Symbol 4153
Full Company Profile

Financial Performance

In 2025, DIVA Laboratories's revenue was 868.84 million, an increase of 0.76% compared to the previous year's 862.32 million. Earnings were 90.54 million, a decrease of -3.33%.

Financial Statements